Talphera, Inc. Files 8-K: Material Agreement, Equity Sales
Ticker: TLPH · Form: 8-K · Filed: Apr 2, 2025 · CIK: 1427925
| Field | Detail |
|---|---|
| Company | Talphera, Inc. (TLPH) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
Related Tickers: TLPH
TL;DR
Talphera (TLPH) filed an 8-K on 3/31/25 for a material agreement & equity sales.
AI Summary
On March 31, 2025, Talphera, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing was made on April 2, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for Talphera, Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and unregistered equity sales can introduce financial and operational risks that require careful monitoring.
Key Players & Entities
- Talphera, Inc. (company) — Registrant
- ACELRX PHARMACEUTICALS INC (company) — Former company name
- March 31, 2025 (date) — Date of earliest event reported
- April 2, 2025 (date) — Filing date
FAQ
What type of material definitive agreement did Talphera, Inc. enter into?
The filing states that Talphera, Inc. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 31, 2025.
What is Talphera, Inc.'s principal executive office address?
Talphera, Inc.'s principal executive offices are located at 1850 Gateway Drive, Suite 175, San Mateo, California 94404.
What was Talphera, Inc.'s former company name?
Talphera, Inc.'s former company name was ACELRX PHARMACEUTICALS INC.
What is the SIC code for Talphera, Inc.?
The Standard Industrial Classification (SIC) code for Talphera, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 2, 2025 regarding TALPHERA, INC. (TLPH).